MAP 2.94% 17.5¢ microba life sciences limited

is map the next cnp, page-8

  1. 47,981 Posts.
    lightbulb Created with Sketch. 2
    nani

    I share (sic) your reaction & concerns. Other recent MAP posts provide valuable insights into recent SP action.

    I invested in MAP due to its apparent operational successes / ongoing increasing cash flow & growth etc. IMHO it now appears that 'those who determine which stocks should be shorted hard' with a view to smashing the SP [and making a $quick] have identified MAP as a possible candidate.

    IMHO Macquaries' business model [ie. investment bank based on aggressive leverage / private equity] is under attack - globally major fin orgs like MS & GS & so called fin gurus such as AG & WB are making well-publicised ann. which engender investor fear in & undermine businesses using high leverage.

    MAPs last Ann Report showed Debt:Equity at ~250% & this appears to be the basis for challenging its business model. Based on what is still happening to CNP, ABS etc. runours, covered & native shorting will be used & re-used. IMHO, despite The Australian's news stories our ASX & the ASIC have proven absolutely, utterly useless in protecting stocks from raiders and thereby have failed genuine investors.

    I am holding & wish you all the best with your investing decisions.

    4YIO - NFA
 
watchlist Created with Sketch. Add MAP (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.